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Determinants of Campylobacter
infection and association with
growth and enteric inflammation in
children under 2 years of age in lowresource settings
Md Ahshanul Haque 1*, James A. Platts-Mills2, Estomih Mduma3, Ladaporn Bodhidatta4,
Pascal Bessong5, Sadia Shakoor6, Gagandeep Kang7, Margaret N. Kosek2,8,12,
Aldo A. M. Lima9, Sanjaya K. Shrestha10, Md. Ashraful Alam 1, Alexandre Havt9,
Amidou Samie 5, Richard L. Guerrant2, Dennis Lang11, Mustafa Mahfuz1, Zulfiqar A. Bhutta6,
Eric R. Houpt2 & Tahmeed Ahmed1
Campylobacter species infections have been associated with malnutrition and intestinal inflammation
among children in low-resource settings. However, it remains unclear whether that association is
specific to Campylobacter jejuni/coli. The aim of this study was to assess the association between both
all Campylobacter species infections and Campylobacter jejuni/coli infections on growth and enteric
inflammation in children aged 1–24 months. We analyzed data from 1715 children followed from
birth until 24 months of age in the MAL-ED birth cohort study, including detection of Campylobacter
species by enzyme immunoassay and Campylobacter jejuni/coli by quantitative PCR in stool samples.
Myeloperoxidase (MPO) concentration in stool, used as a quantitative index of enteric inflammation,
was measured. The incidence rate per 100 child-months of infections with Campylobacter jejuni/coli
and Campylobacter species during 1–24 month follow up were 17.7 and 29.6 respectively. Female sex
of child, shorter duration of exclusive breastfeeding, lower maternal age, mother having less than 3
living children, maternal educational level of <6 years, lack of routine treatment of drinking water, and
unimproved sanitation were associated with Campylobacter jejuni/coli infection. The cumulative burden
of both Campylobacter jejuni/coli infections and Campylobacter species were associated with poor
growth and increased intestinal inflammation.
Campylobacter species are curved, gram-negative bacterial enteropathogens with diverse human and animal reservoirs, which have been associated with linear growth shortfalls in children in low-resource settings1–3. There are
more than 25 species of Campylobacter, of which the thermotolerant variants such as Campylobacter jejuni and
Campylobacter coli are thought to most commonly infect humans4,5. There are multiple microbiologic approaches
for detection of Campylobacter species, including bacterial culture, enzyme immunoassay (EIA), and PCR.
While both culture and PCR assays can target Campylobacter jejuni and Campylobacter coli, PCR is substantially
more sensitive. The most commonly used EIA tests have been shown to detect a broader range of Campylobacter
species6.
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Characteristics, n (%)

Bangladesh

Brazil

India

Nepal

Peru

Pakistan

South Africa

Tanzania

Overall

Male sex

108 (51.4)

89 (53.9)

105 (46.3)

122 (53.7)

105 (54.1)

120 (48.8)

120 (50.6)

105 (50.2)

874 (51.0)

Days of exclusive breastfeeding†

143.2 ± 42.7

93.7 ± 57.8

105.4 ± 42.9

92.5 ± 54.5

89.5 ± 61.3

19.9 ± 22.7

38.6 ± 26.3

62.2 ± 35

78.6 ± 57.7

Birth weight (kg)†

2.8 ± 0.4

3.4 ± 0.5

2.9 ± 0.4

3 ± 0.4

3.1 ± 0.4

2.7 ± 0.4

3.2 ± 0.5

3.2 ± 0.5

3.0 ± 0.5

Weight for age z-score at Enrollment†

−1.3 ± 0.9

−0.2 ± 1

−1.3 ± 1

−0.9 ± 1

−0.6 ± 0.9

−1.4 ± 1

−0.4 ± 1

−0.1 ± 0.9

−0.8 ± 1.1

Length for age z−score at Enrollment†

−0.96 ± 1

−0.8 ± 1.1

−1 ± 1.1

−0.7 ± 1

−0.9 ± 1

−1.3 ± 1.1

−0.7 ± 1

−1 ± 1.1

−0.9 ± 1.1

Length for age z-score at 24 month†

−2.0 ± 0.9

0 ± 1.1

−1.9 ± 1

−1.3 ± 0.9

−1.9 ± 0.9

N/A

−1.7 ± 1.1

−2.7 ± 1

−1.7 ± 1.2

Maternal age (years)†

25.0 ± 5.0

25.4 ± 5.6

23.9 ± 4.2

26.6 ± 3.7

24.8 ± 6.3

28.1 ± 5.9

27 ± 7.2

29.1 ± 6.5

26.3 ± 5.9

Maternal weight (kg)

49.7 ± 8.5

62 ± 11.5

50.3 ± 9.3

56.2 ± 8.3

56.3 ± 9.6

50.7 ± 9.6

68 ± 15.3

55.7 ± 8.8

55.9 ± 12

Maternal height (cm)†

149.0 ± 5.0

155.1 ± 6.7

151.1 ± 5.2

149.7 ± 5.3

150.2 ± 5.5

153.4 ± 5.7

158.7 ± 6.6

155.9 ± 5.9 152.9 ± 6.6

Maternal educational level < 6 y

133 (63.3)

22 (13.3)

80 (35.2)

59 (26)

44 (22.7)

202 (82.1)

5 (2.1)

75 (35.9)

620 (36.2)

Mother has less than 3 living children

160 (76.2)

113 (68.5)

157 (69.8)

199 (87.7)

111 (57.2)

105 (42.7)

141 (59.5)

58 (27.8)

1044 (61)

Ownership of chickens/ducks

3 (1.4)

1 (0.6)

14 (6.2)

73 (32.2)

75 (38.7)

144 (62.3)

87 (37.2)

204 (97.6)

601 (35.4)

Ownership of cows/bulls

1 (0.5)

0 (0)

5 (2.2)

3 (1.3)

0 (0)

146 (59.4)

33 (13.9)

157 (75.1)

345 (20.1)

Routine treatment of drinking water

130 (61.9)

10 (6.1)

7 (3.1)

98 (43.2)

32 (16.5)

0 (0)

12 (5.1)

12 (5.7)

301 (17.6)

Improved drinking water source

210 (100)

165 (100)

227 (100)

227 (100)

184 (94.9)

246 (100)

196 (82.7)

89 (42.6)

1544 (90.0)

Improved latrine

210 (100)

165 (100)

121 (53.3)

227 (100)

66 (34)

197 (80.1)

232 (97.9)

19 (9.1)

1237 (72.1)

Improved floor

204 (97.1)

165 (100)

222 (97.8)

109 (48)

69 (35.6)

81 (32.9)

231 (97.5)

13 (6.2)

1094 (63.8)

Monthly income < $150

69 (32.9)

161 (97.6)

19 (8.4)

106 (46.7)

58 (29.9)

115 (46.8)

179 (75.5)

0 (0)

707 (41.2)

Table 1. General characteristics of the study subjects (n = 1715). †Mean ± Standard deviation.

Campylobacter infections in young children have been associated with dysentery, diarrhea, and malnutrition1,5,7. Environmental enteric dysfunction is a subclinical intestinal disorder which is highly prevalent in
low-resource settings and characterized by intestinal inflammation and alteration in gut structure and function8–10. Myeloperoxidase (MPO) concentration in the stool can be used as a quantitative index of enteric
inflammation11 and previous studies suggests MPO as is a simple, noninvasive, and a direct marker of inflammation1,12–14. MPO, an enzyme found in granulocytes, is involved with the release of hypochlorous acid. It induces
oxidative tissue damage of host tissue following extracellular phagocytic activation at the inflammatory site,
resulting in microbial destruction15,16. The increase in mucosal MPO levels can be used as a biomarker in human
patients with inflammatory bowel disease17,18.
The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences
for Child Health and Development (MAL-ED) study is a birth cohort performed at 8 sites in South America,
sub-Saharan Africa, and Asia19. Campylobacter species were originally detected by EIA in this study, and a previous analysis showed a strong association between Campylobacter species infection and growth1. However, the
degree to which this association was specific to Campylobacter jejuni and Campylobacter coli, other Campylobacter
species, or both remains unclear. Here, we sought to identify risk factors for Campylobacter jejuni/coli infection
and assess the association with enteric inflammation and linear growth in children and compare these associations with the burden of infestation by Campylobacter species by EIA.

Results

General characteristics. A total of 1715 participants who completed follow-up to 24 months contributed
34,622 surveillance stool samples tested for Campylobacter jejuni/coli by quantitative PCR whereas Campylobacter
species done by EIA was tested during 1–12, 15, 18, 21, 24 months on 22,614 surveillance stool samples. The
demographic characteristics of the study participants are presented in Table 1. The prevalence of Campylobacter
jejuni/coli and Campylobacter species in surveillance stool samples during 1–24 months by sites is shown in
Fig. 1. The overall prevalence of Campylobacter species infections was approximately twice that of C. jejuni/coli
infections. Both peaked at approximately one year of age and then subsequently declined for C. jejuni/coli and
was stable for Campylobacter species. The burden was highest in children at the Bangladesh and Tanzania sites.
Incidence and incidence rate of Campylobacter infection. The cumulative incidences of
Campylobacter jejuni/coli and Campylobacter species were 86.1% and 90.0% respectively. The incidence rate per
100 child-months of infections with Campylobacter jejuni/coli and Campylobacter species during 1–24 month follow up were 17.7 (95% CI: 17.0, 18.5) and 29.6 (95% CI: 28.16, 30.3) respectively. The incidence and incidence rate
were highest for Bangladesh and Tanzania sites (Table 2). We identified factors associated with Campylobacter
jejuni/coli and Campylobacter species detection using negative binomial regression in surveillance stool samples across all sites (Table 3). The incidence rate for infection of Campylobacter jejuni/coli in female children
was 7% higher [IRR: 1.07 (95% CI: 1.07, 1.14); p = 0.048] than in male children. Shorter duration of exclusive
breastfeeding [IRR: 0.98 per additional month (95% CI: 0.95, 0.99); p = 0.035], lower maternal age in years [IRR:
0.99 per year (95% CI: 0.97, 0.99); p < 0.001], mother having no less than 3 living children [IRR: 1.15 (95% CI:
1.05, 1.26); p = 0.002], maternal education not greater than or equal to 6 years [IRR: 1.09 (95% CI: 1.01, 1.17);
p = 0.021], lack of treatment of drinking water [IRR: 1.26 (95% CI: 1.14, 1.40); p = 0.002], and unimproved sanitation [IRR: 1.11 (95% CI: 1.00, 1.23); p = 0.043] were associated with infection with Campylobacter jejuni/coli.
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Prevalence of Campylobacter species by enzyme immunoassay
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Figure 1. Prevalence of Campylobacter jejuni/coli and Campylobacter species in stool during 1–24 months by
age group.

Furthermore, female children, shorter duration of exclusive breastfeeding, enrollment weight-for-age z-score
(WAZ), lower maternal age, mother having no less than 3 living children, maternal education not greater than
or equal to 6 years, no treatment of drinking water, unimproved sanitation, and household ownership of cattle/
poultry were also found to be more strongly associated with Campylobacter species as detected by EIA compared
to Campylobacter jejuni/coli as detected by qPCR. The incidence rate ratio for the sites of Brazil (BR), India (IN),
Nepal (NP), Peru (PE), Pakistan (PK), and South Africa (SA) were lower compared to the Bangladesh site.

Association of Campylobacter infections with growth and enteric inflammation. The cumulative
burden of both Campylobacter jejuni/coli infections [−0.18 difference in 24-month length-for-age z-score (LAZ)
for children with high vs. low burden of infection (95% CI: −0.30, −0.06), p = 0.004] and Campylobacter species
[−0.31 difference in 24-month LAZ (95% CI: −0.46, −0.15), p < 0.001] were associated with poor growth, with a
stronger association seen for Campylobacter species both overall and for the majority of sites (Table 4). Meanwhile,
after controlling for infection with enteroaggregative E. coli (EAEC), heat-labile enterotoxin-producing E. coli
(LT-ETEC), heat-stable enterotoxin-producing E. coli (ST-ETEC), Shigella/enteroinvasive E. coli (Shigella/EIEC),
both Campylobacter species and Campylobacter jejuni/coli infections were also clearly and consistently associated
with increased enteric inflammation as measured by MPO, with a stronger association seen for Campylobacter
jejuni/coli (Table 5).

Discussion

In this prospective multisite birth cohort study, we documented a high burden of Campylobacter infections, with
most of the children having Campylobacter detected in a monthly surveillance stool sample by one year of age
at seven of the eight sites. The burden was highest in Bangladesh and Tanzania and consistent with prior studies20,21. Our study also shows the incidence rates are more among Bangladesh and Tanzania than other sites (for
instance, Brazil, India, Nepal, Peru, Pakistan, South Africa). Overall, the incidence of Campylobacter species
infections is approximately 65% higher than that of Campylobacter jejuni/coli alone. In keeping with data from
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Campylobacter jejuni/coli (PCR)

Campylobacter species (EIA)

Sites

Incidence rate per 100
Child-months (95% CI)

Cumulative Incidence rate per 100
incidence
Child-months (95% CI)

Cumulative
incidence

Bangladesh

28.3 (26.2, 30.6)

99.5

44.1 (41.6, 46.8)

100.0

Brazil

4.2 (3.4, 5.1)

47.9

8.2 (6.8, 10)

54.6

India

12.9 (11.7, 14.4)

89.0

28.4 (25.9, 31.3)

90.3

Nepal

18.8 (17.4, 20.2)

96.5

21.2 (19.5, 23.1)

93.0

Peru

16.9 (15.5, 18.3)

94.9

23.2 (21, 25.5)

93.3

Pakistan

16.3 (14.9, 17.7)

92.3

49.7 (47, 52.5)

99.2

South Africa

5.7 (5.0, 6.5)

62.5

13.3 (12.1, 14.6)

83.5

Tanzania

36.8 (34.2, 39.6)

100.0

39.8 (37.3, 42.4)

99.0

Overall

17.7 (17.0, 18.5)

86.1

29.2 (28.1, 30.3)

90.2

Table 2. Incidence rate per 100 Child-months and cumulative incidence of Campylobacter jejuni/coli and
Campylobacter species infection by site. Incidence rate per was calculated using negative binomial regression
where outcome variables were the number of infection of Campylobacter jejuni/coli and Campylobacter species
infection and offset variables were log of number of follow up.

previous study by Amour et al., showed that promotion of exclusive breastfeeding, drinking water treatment,
improved latrines, and targeted antibiotic treatment may reduce the burden of Campylobacter species infection
[1], our study found that Campylobacter infections were significantly associated with female sex, shorter duration
of exclusive breastfeeding, lower maternal age, less maternal education, lack of treatment of drinking water, and
unimproved sanitation. Birth weight-for-age is a marginal predictor for Campylobacter species whereas the presence of Campylobacter species is associated with growth shortfalls1. Among malnourished children from a case
control study where the cases comprised of children with weight-for-age z score (WAZ) < −2 aged 6–23 months
in Dhaka, prevalence of Campylobacter was high compared to healthy (control) children [weight-for-age z score
(WAZ) > −1] but the adjusted effect size was not statistically significant20.
The association of Campylobacter jejuni/coli infection with nutritional status and fecal MPO concentrations
of children less than 2, after controlling for seasonality and potential confounders including socio-economic
and demographic factors, suggests that Campylobacter jejuni/coli have influence on childhood malnutrition and
intestinal inflammation20. This finding suggests that Campylobacter can drive intestinal inflammation, which is
partly due to altering of the composition of the intestinal microbiota, impairing the intestinal barrier, and priming
the intestine for chronic inflammatory responses and is consistent with results of other studies1,7. Meanwhile, the
association with growth was stronger for Campylobacter species than with Campylobacter jejuni/coli, which might
suggest that non-jejuni/coli species are more strongly associated with poor growth. However, the association with
inflammation is stronger for Campylobacter jejuni/coli. Further elucidation of the prevalence, clinical relevance,
and mechanisms for association with poor growth are needed for diverse Campylobacter species.
There were some limitations in this paper. As an observational cohort study, the causality of the associations
between Campylobacter infections and both intestinal inflammation and linear growth cannot be confirmed but
can be inferred based on a number of criteria, including the appropriate adjustment of the models for potential confounders, the strength and consistency of the associations, and the biological plausibility. We have not
established a temporal relationship between infections and the outcomes, which would require structured longitudinal models, however previous analyses using such approaches found consistent results for the association
between Campylobacter infections and linear growth2. These findings suggest that Campylobacter species other
than Campylobacter jejuni/coli may be more strongly associated with child growth shortfalls. Further work is
needed to directly assess the epidemiology and impact of individual Campylobacter species. Secondly, interventions that reduce exposure to these diverse Campylobacter species need to be identified, and the impact of these
interventions on child growth need to be assessed. We compared the associations of Campylobacter species and
Campylobacter jejuni/coli infections with growth and found that other non-jejuni/coli species were also associated
with poor growth, however, the absence of direct microbiologic assays for specific non-jejuni/coli Campylobacter
species limited our ability to understand what species or group of species are driving these associations.
In conclusion, children harboring risk factors such as female sex, shorter duration of exclusive breastfeeding,
lower maternal age in years, maternal education not greater than or equal to 6 years, mother having less than
3 living children, lack of routine treatment of drinking water, unimproved sanitation, and ownership of cattle/
poultry were more prone to Campylobacter infection and thereby have compromised nutritional status; such
infection was higher in Bangladesh and Tanzania compared to other sites. The burden of Campylobacter was associated with increased enteric inflammation among children in the first 2 years of life. Campylobacter species had
a stronger association with growth whereas the association with inflammation was strongest for Campylobacter
jejuni/coli.

Method

Study design and participants.

The MAL-ED study design and methodology have been previously
described19. Briefly, children were enrolled November, 2009 to February, 2012 from the community within
17 days of birth at eight locations: Dhaka, Bangladesh; Vellore, India; Bhaktapur, Nepal; Naushero Feroze,
Pakistan; Venda, South Africa; Haydom, Tanzania; Fortaleza, Brazil; and Loreto, Peru. Children were included
if the maternal age was 16 years or older, their family intended to remain in the study area for at least 6 months
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Risk Factors by
Category

Campylobacter jejuni/coli (PCR) Campylobacter species (EIA)
IRR (95% CI)

p-value

IRR (95% CI)

0.048

1.07 (1.01, 1.13)

p-value

Sex of child
Male

Reference

Female

1.07 (1.00, 1.14)

Reference
0.014

Duration of EBF
(month)

0.98 (0.95, 0.99)

0.035

0.97 (0.95, 0.99)

0.004

Enrollment WAZ

1.00 (0.97, 1.04)

0.814

1.03 (1.01, 1.06)

0.015

Maternal age in
years

0.99 (0.98, 0.99)

<0.001

0.98 (0.98, 0.99)

<0.001

0.021

1.12 (1.05, 1.19)

0.002

1.25 (1.16, 1.34)

0 < 0.001

1.39 (1.27, 1.53)

0.043

1.16 (1.07, 1.26)

Maternal educational level < 6 y
No

Reference

Yes

1.09 (1.01, 1.17)

Reference
0.001

Mother has less than 3 living children
Yes

Reference

No

1.15 (1.05, 1.26)

Reference
<0.001

Routine treatment of drinking water
Yes

Reference

No

1.26 (1.14, 1.4)

Reference
<0.001

Improved sanitation
Yes

Reference

No

1.11 (1.00, 1.23)

Reference
<0.001

Household ownership of cattle/poultry
No

Reference

Yes

1.07 (0.97, 1.17)

0.167

1.12 (1.04, 1.21)

Reference
0.003

alpha (α)

0.13 (0.11, 0.16)

<0.001

0.05 (0.03, 0.08)

<0.001

Table 3. Risk factors for Campylobacter detection in monthly surveillance stool samples. Model: Negative
binomial regression; Dependent variable: Number of infection during follow up (1–24 m); Offset: Log of
total number of follow up; alpha (α): dispersion parameter; Adjusted for site and all variables included in
multivariable model.

from enrolment, they were from a singleton pregnancy, and they had no other siblings enrolled in the study.
Children with a birthweight or enrolment weight of less than 1500 gm and children diagnosed with congenital
disease or severe neonatal disease were excluded. The study was approved by the Research Review Committee
and the Ethical Review Committee of icddr,b (Bangladesh), the Local Institutional Review Board at the Federal
Universisty of Ceará and the national IRB Conselho Nacional de Ética em Pesquisa (Brazil), the Christian Medical
College Institutional Review Board and the Emory University Institutional Review Board (India), the Nepal
Health Research Council and Walter Reed Institute of Research (Nepal), the Ethics Committee of Asociacion
Benefica PRISMA, the Regional Health Directorate of Loreto and the IRB of Johns Hopkins Bloomberg School of
Public Health (Peru), the Ethical Review Committee of Aga Khan University (Pakistan), the Institutional Review
Boards at the University of Venda (South Africa), the National Institute for Medical Research (Tanzania), and the
Institutional Review Board of the University of Virginia (UAS). Written informed consent was obtained from the
parents or legal guardian of every child19,22. All methods were performed in accordance with the relevant guidelines and regulations.

Data collection. Household demographics, presence of siblings, maternal characteristics, and other data on
the child’s birth and anthropometry were obtained at enrollment19. The socioeconomic status (SES) of families
was assessed at 6, 12, 18, and 24 months. SES score, the water/sanitation, assets, maternal education and income
(WAMI) index was developed using composite indicators including the variables such as access to improved
water and sanitation, eight selected assets, maternal education, and household income23. Improved water and sanitation were defined following World Health Organization guidelines24. Treatment of drinking water was defined
as filtering, boiling, or adding bleach1. Anthropometric measurements and vaccination history were collected
monthly. Details of illness and child feeding practices were collected during twice-weekly household visits25.
Stool samples were collected monthly and were preserved, transported, and processed at all sites using harmonized protocols26. Child anthropometry was measured using standard scales (seca gmbh & co. kg., Hamburg,
Germany). Length-for-age Z score (LAZ) was calculated through the use of the 2006 WHO standards for children27. The Z-score scale, calculated as (observed value - average value of the reference population)/standard
deviation value of reference population, is linear and therefore a fixed interval of Z-scores has a fixed length difference in cm for all children of the same age. Z-scores are also sex-independent, thus permitting the evaluation
of children’s growth status by combining sex and age groups28.
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Campylobacter jejuni/coli (PCR)

Campylobacter species (EIA)

Sites

Coef. (95% CI)

p-value

Coef. (95% CI)

p-value

Bangladesh

−0.33 (−0.58, −0.09)

0.008

−0.51 (−0.84, −0.18)

0.002

Brazil

−0.39 (−1.27, 0.48)

0.374

−0.25 (−1.07, 0.57)

0.543

India

−0.28 (−0.61, 0.05)

0.096

−0.17 (−0.49, 0.14)

0.284

Nepal

−0.30 (−0.59, −0.01)

0.042

−0.40 (−0.83, 0.02)

0.062

Peru

−0.07 (−0.40, 0.27)

0.692

−0.40 (−0.77, −0.03)

0.035

South Africa

−0.62 (−1.20, −0.05)

0.034

−0.13 (−0.85, 0.59)

0.719

Tanzania

0.13 (−0.10, 0.36)

0.276

−0.24 (−0.58, 0.11)

0.180

Overall

−0.18 (−0.30, −0.06)

0.004

−0.31 (−0.46, −0.15)

<0.001

Table 4. Association of Campylobacter jejuni/coli and Campylobacter species infection burden on children
growth at 24 months. Adjusted in linear regression model for sex, WAMI Index (water/sanitation, assets,
maternal education, and income); enrollment length-for-age z score; maternal height; poultry/cattle in house,
mother has less than 3 living children and site for overall estimate; Dependent variable: length-for-age z score at
24 m; Independent variables: Campylobacter burden.
Stool myeloperoxidase (MPO) concentration
Campylobacter jejuni/coli (PCR) Campylobacter species (EIA)
Sites

Coef. (95% CI)

p-value

Coef. (95% CI)

p-value

Bangladesh

0.20 (0.08, 0.31)

0.001

0.23 (0.13, 0.33)

<0.001

Brazil

0.54 (0.19, 0.90)

0.003

0.49 (0.24, 0.74)

<0.001

India

0.40 (0.27, 0.53)

<0.001

0.24 (0.14, 0.33)

<0.001

Nepal

0.34 (0.23, 0.45)

<0.001

0.24 (0.13, 0.34)

<0.001

Peru

0.26 (0.12, 0.41)

<0.001

0.22 (0.09, 0.35)

0.001

Pakistan

0.28 (0.15, 0.41)

<0.001

0.20 (0.10, 0.30)

<0.001

South Africa

0.37 (0.19, 0.55)

<0.001

0.17 (0.05, 0.30)

0.007

Tanzania

0.24 (0.13, 0.34)

<0.001

0.09 (−0.01, 0.19)

0.088

Overall

0.29 (0.24, 0.34)

<0.001

0.20 (0.16, 0.24)

<0.001

Table 5. Association between Campylobacter jejuni/coli and enteric inflammation (stool myeloperoxidase).
Adjusted in the in GEE model for sex, age, WAMI Index (water/sanitation, assets, maternal education, and
income); enrollment length-for-age z score; maternal height; number of children, poultry/cattle in house,
seasonality, site for overall estimate, some alternative pathogens (EAEC, LT-ETEC, ST-ETEC, Shigella/EIEC),
and age as time variable. Dependent variable was log(MPO); Independent variables: presence of Campylobacter
at each months.

Laboratory testing. Stool samples were collected without fixative by field workers and raw stool aliquots were kept at −80 °C before nucleic acid extraction. All lab testing was done at the site specific laboratories11,14. Stool samples were assayed for Campylobacter species by enzyme immunoassay (ProSpecT, Remel,
Lenexa, KS, USA). In addition, myeloperoxidase (MPO) (Alpco, Salem, New Hampshire) was measured using
commercially-available Enzyme Linked Immunosorbent Assay (ELISA) kits following the instructions of the
manufacturers1,8. Campylobacter jejuni/coli were detected in the stool samples by quantitative PCR targeting
the cadF gene using the TaqMan Array Card (TAC) platform, a compartmentalized probe-based real-time PCR
assays for detecting enteropathogens in fecal samples, as previously described22,29. The analytic cutoff of each
pathogen was a quantification cycle (Cq) of 35; thus, a Cq < 35 was considered positive20,30.
Statistical methods. All statistical tests were performed in STATA 14 (Stata Corporation, College Station,
TX). Campylobacter burden was defined as the number of pathogens detected divided by the number of stools
collected and was scaled divided by (10th vs 90th percentile). Descriptive statistics such as proportion, mean and
standard deviation for symmetric data, and median with inter‐quartile range (IQR) for asymmetric quantitative variables were used to summarize the data. Chi-square and proportion test was used to see the association
between two categorical variables and t-test was used to see the mean difference between two groups for symmetric distribution. Cumulative incidence of Campylobacter jejuni/coli and Campylobacter species was defined
as the proportion of subjects who were infected at least once during the study period. Incidence rates and risk
factors associated with Campylobacter detection in surveillance stool samples were calculated using negative
binomial regression models due to over dispersion. In the final multiple negative binomial regression model,
the following variables were considered for inclusion using stepwise forward selection: child sex, duration of
exclusive breastfeeding in months, enrollment weight for age z-score, maternal age in years, maternal education
greater than or equal to 6 years, mother having less than 3 living children, routine treatment of drinking water,
improved sanitation, and household ownership of cattle/poultry. The MPO values were log‐transformed before
the analysis. We excluded children from the Pakistan site for growth analysis, owing to bias noted in a subset of
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length measurements at this site. Seasonality was calculated via the terms sin(2mπ/12) + cos(2mπ/12), where “m”
is the calendar month1,31. Associations between Campylobacter infection and inflammation was estimated using
generalized estimating equations to fit regression models after adjusting for seasonality, sex, age, water/sanitation,
assets, maternal education, and income (WAMI) index; enrollment length-for-age; maternal height; poultry/
cattle in house, some alternative pathogens which were significantly associated with log(MPO) such as enteroaggregative E. coli (EAEC), heat-labile enterotoxin-producing E. coli (LT-ETEC), heat-stable enterotoxin-producing
E. coli (ST-ETEC), Shigella/enteroinvasive E. coli (Shigella/EIEC), and site for overall estimate and age in month
as time variable32. The Gaussian family with identity link was used for the continuous outcome of log(MPO). To
access and compare the associations of Campylobacter jejuni/coli and Campylobacter species infection burden
on growth at 24 months of age, we used multi-variable linear regression after adjusting for site and the necessary
covariates.
Received: 22 July 2019; Accepted: 31 October 2019;
Published: xx xx xxxx
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